CN117180161A - Willow leaf extract and extraction method and application thereof - Google Patents
Willow leaf extract and extraction method and application thereof Download PDFInfo
- Publication number
- CN117180161A CN117180161A CN202311401209.4A CN202311401209A CN117180161A CN 117180161 A CN117180161 A CN 117180161A CN 202311401209 A CN202311401209 A CN 202311401209A CN 117180161 A CN117180161 A CN 117180161A
- Authority
- CN
- China
- Prior art keywords
- extraction method
- solution
- willow leaf
- methanol
- hydrochloric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000124033 Salix Species 0.000 title claims abstract description 51
- 239000000284 extract Substances 0.000 title claims abstract description 51
- 238000000605 extraction Methods 0.000 title claims abstract description 30
- 230000002087 whitening effect Effects 0.000 claims abstract description 23
- 239000000243 solution Substances 0.000 claims description 50
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 39
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 34
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 26
- 239000011259 mixed solution Substances 0.000 claims description 26
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 claims description 25
- 239000002002 slurry Substances 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 20
- 239000012043 crude product Substances 0.000 claims description 18
- 239000003480 eluent Substances 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 18
- 239000011780 sodium chloride Substances 0.000 claims description 17
- 230000010355 oscillation Effects 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 11
- 229920005989 resin Polymers 0.000 claims description 11
- 238000004537 pulping Methods 0.000 claims description 10
- 238000000746 purification Methods 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000012044 organic layer Substances 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 abstract description 18
- 241000196324 Embryophyta Species 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 241000646858 Salix arbusculoides Species 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 230000008021 deposition Effects 0.000 abstract description 3
- 239000000049 pigment Substances 0.000 abstract description 3
- 230000011506 response to oxidative stress Effects 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 25
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 16
- 102000003425 Tyrosinase Human genes 0.000 description 13
- 108060008724 Tyrosinase Proteins 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 210000002421 cell wall Anatomy 0.000 description 7
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 230000019612 pigmentation Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 229960003638 dopamine Drugs 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 235000008302 Chamaenerion angustifolium Nutrition 0.000 description 3
- 241000721098 Epilobium Species 0.000 description 3
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 3
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 3
- 229940117893 apigenin Drugs 0.000 description 3
- 235000008714 apigenin Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000218998 Salicaceae Species 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 235000021384 green leafy vegetables Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- -1 flavonoid compound Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000036564 melanin content Effects 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The application discloses a willow leaf extract and an extraction method and application thereof, and belongs to the technical field of plant extraction. According to the application, through adjusting the extraction process, the willow leaf can be fully extracted, the effective components in the willow leaf are fully extracted, and the yield of the extract can be effectively ensured. The extract obtained by the extraction method provided by the application contains various whitening active ingredients, and can effectively relieve oxidative stress and inflammatory reaction, so that pigment deposition is reduced, and further the whitening effect is realized.
Description
Technical Field
The application belongs to the technical field of plant extraction, and particularly relates to a willow leaf extract and an extraction method and application thereof.
Background
The herba Salicis Babylonicae, also called herba Violae, herba Cymbopogonis Citrari, is dry whole herb of Salicaceae genus Salicaceae plant Salicaceae. The willow leaf is a perennial herb plant, has more than 200 parts worldwide, is mainly produced in the sand of a stream bed, the sunny and wet places of a ditch and a lake side and in the bushes with the altitude of 1000-4000 meters, and is widely distributed in places such as Sichuan, guizhou, yunnan, jilin, liaoning, jiangsu, zhejiang and the like.
The willow leaf is widely applied to folk medicines, such as prostate, urinary tract, bladder and gastrointestinal diseases or inflammations, epilepsy and the like. The whole herb of the flowers, roots and the whole herb with roots of the willow herb can be used as medicines, wherein the whole herb has the effects of clearing heat and detoxicating, promoting diuresis and stopping diarrhea, promoting digestion and regulating qi and activating blood circulation to set bone, and is mainly used for treating fracture, traumatic injury, furuncle and carbuncle swelling and traumatic hemorrhage; flower, bitter, slightly sweet and cool, has the effects of clearing heat and relieving pain, and regulating menstruation and astringing leucorrhea, and is used for treating toothache, acute conjunctivitis, sphagitis, irregular menstruation and excessive leucorrhea; root, bitter and flat, has the effects of regulating qi, removing food retention, promoting blood circulation, relieving pain, removing toxic substance and detumescence, and is used for amenorrhea, gastralgia, food stagnation and distention. Currently, willow leaves are mostly used for hemostasis, menstrual disorder, prostatitis and sleep problems, and in addition, young leaves of willow leaves are often used as food and feed.
The whitening mechanism mainly comprises a plurality of ways of directly whitening and resisting oxidation by reducing melanin content, wherein the ways of inhibiting melanin formation are more common. Melanin is a macromolecule commonly found in the human body, particularly in the eyes, skin and pigment tissues; the density of melanin determines the color of the tissue. Melanin can protect skin from ultraviolet rays and free radicals, but also can cause skin aging and pigmentation, and cause excessive melanin production to cause problems of darkness, color spots and the like of the skin. Skin aging is the result of complex interactions between epidermis, dermis, subcutaneous fat and extracellular substrates, leading to pigmentation, wrinkling, cramping and other activities caused by oxidative stress, and furthermore, skin aging leads to reduced secretion of hormones, leading to reduced activity and function of skin cells. Tyrosinase is an indispensable enzyme in the melanogenesis process. Therefore, compounds having high antioxidant activity are expected to inhibit pigmentation by affecting biosynthesis of melanin and tyrosinase to promote whitening and delay aging.
At present, the whitening products on the market mainly comprise chemical products, biological products and natural plants, wherein the natural plant whitening agent is derived from natural plants, has good safety, rich resources, is easy to obtain and has low cost, so the whitening products become one of the main lines of research in recent years, but no related report of using the willow leaf extract in cosmetics is seen.
Disclosure of Invention
Aiming at the prior art, the application provides a willow leaf extract, an extraction method and application thereof, which are used for solving the technical problem of low extraction rate of active ingredients of willow leaf and developing new application of the willow leaf extract.
In order to achieve the above purpose, the technical scheme adopted by the application is that the application provides an extraction method of a willow leaf extract, which comprises the following steps:
s1: mixing fresh willow leaf with acetic acid solution according to a feed liquid ratio of 1 g:5-10 mL, and pulping to obtain slurry;
s2: mixing the slurry with sodium chloride solution, and carrying out ultrasonic oscillation for 10-20 min to obtain a mixture;
s3: adding a methanol-hydrochloric acid mixed solution into the mixture, heating and refluxing for 30-60 min at 45-100 ℃, filtering, and collecting filtrate;
s4: adding an organic extractant into the filtrate, standing for 30-45 min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s5: purifying the crude product by using XDA-5 macroporous resin column as purification column and ethanol solution as eluent, collecting eluent, concentrating, and drying.
The beneficial effects of the application adopting the technical scheme are as follows: according to the application, when the willow leaf is extracted, the willow leaf is firstly mixed with acetic acid for pulping, and the acetic acid can not only reduce the pH value of a willow leaf cell system and enable the cell wall to be dissociated to promote the release and extraction of active ingredients, but also promote the stability of the active ingredients such as polyphenol substances and reduce the sensitivity degree and the possibility of activity loss.
After the slurry is obtained, sodium chloride solution is added into the slurry, and the sodium chloride solution can regulate the osmotic pressure of the willow cells, promote water molecules to flow out from the inside of the cells, shrink the cells and release intracellular components, thereby improving the extraction rate of the active ingredients; in addition, sodium chloride can also improve solubility of components such as quercetin, so that the effective components are maximally dissolved in the extraction solvent. After the sodium chloride solution is added, the cell wall structure is influenced by the ultrasonic wave, namely the micro-bubble cracking and the shock wave effect generated by the ultrasonic wave, so that the cell wall is cracked, and the release of target components is facilitated; ultrasound can also increase mass transfer rate of substances in the liquid phase, allowing rapid release of target components from plant tissue into the solvent by increasing convection and diffusion of the liquid phase.
The cell walls of the salix leaf vegetables are basically completely destroyed after the salix leaf vegetables are treated by the acetic acid and sodium chloride solution, and then a methanol-hydrochloric acid mixed solution is added, wherein the hydrochloric acid can change the pH value of the solution, so that the ionic form or molecular structure of the active ingredients is changed, the solubility of the active ingredients is improved, the active ingredients are more soluble in the solvent, and certain unstable compounds can be converted into stable forms, so that the content of the active ingredients is ensured; moreover, the hydrochloric acid can further destroy the cell tissues, which is beneficial to release of the effective components in the cells; the methanol is used as a solvent to better dissolve the active ingredients in the willow leaf, and the active ingredients in the willow leaf are completely dissolved in the methanol in combination with the pretreatment, and then the cosmetic-grade willow leaf extract can be obtained through the purification treatment.
On the basis of the technical scheme, the application can be improved as follows.
Further, the volume concentration of the acetic acid solution is 5 to 10%.
Further, the concentration of the sodium chloride solution is 0.1-0.5 wt%, and the volume ratio of the slurry to the sodium chloride solution is 1:1-3.
Further, the power of ultrasonic oscillation is 200-300W, and the frequency is 25-40 KHz.
Further, the volume ratio of the methanol to the hydrochloric acid in the methanol-hydrochloric acid mixed solution is 3-5:1.
Further, the volume ratio of the mixture to the methanol-hydrochloric acid mixed solution is 1:1-3.
Further, the organic extractant is ethyl acetate, and the filtrate is mixed with ethyl acetate in equal volume.
Further, the XDA-5 macroporous resin column takes XDA-5 macroporous resin as a filler, and the specification is 65 x 100mm; the volume fraction of ethanol solution used for elution was 70%.
The application also discloses the willow leaf extract extracted by the extraction method.
The willow leaf is rich in rutin, apigenin, quercetin and other components, and the components can be effectively extracted by adopting the extraction process. Wherein apigenin is a natural plant flavonoid compound, has an antioxidation effect, can effectively remove free radicals, lighten oxidative stress and inhibit excessive production of melanin; meanwhile, the apigenin has anti-inflammatory property, can reduce the damage of inflammatory reaction to skin, helps to ease and alleviate some pigmentation conditions caused by sun exposure, environmental pollution and the like, and achieves the effect of skin whitening. Rutin also has antioxidant and anti-inflammatory properties, and it also reduces the activity of the maillard cells and inhibits the overproduction of melanin, thereby helping to alleviate some of the mild pigmentation problems. In addition to the antioxidant and anti-inflammatory effects, the quercetin can effectively inhibit the activity of tyrosinase, and can reduce the synthesis of melanin by inhibiting tyrosinase, so that the quercetin is helpful for reducing color spots and brightening skin.
The willow leaf extract extracted by the application contains a plurality of active components with anti-inflammatory and antioxidant effects, and can effectively relieve pigmentation caused by oxidative stress and inflammation, thereby producing good whitening effect.
The application also discloses application of the willow leaf extract in preparing cosmetics. The prepared cosmetic has excellent whitening effect and can be used as a whitening cosmetic.
The beneficial effects of the application are as follows:
1. according to the application, through adjusting the extraction process, the willow leaf can be fully extracted, the effective components in the willow leaf are fully extracted, and the yield of the extract can be effectively ensured.
2. The extract obtained by the extraction method provided by the application contains various whitening active ingredients, and can effectively relieve oxidative stress and inflammatory reaction, so that pigment deposition is reduced, and further the whitening effect is realized.
Detailed Description
The following describes the present application in detail with reference to examples.
Example 1
A willow leaf extract is extracted by the following process:
s1: mixing fresh willow leaves with acetic acid solution with volume concentration of 8% according to the feed liquid ratio of 1g to 8mL, and pulping to obtain slurry;
s2: mixing the slurry with a sodium chloride solution with the concentration of 0.3wt% according to the volume ratio of 1:2, and carrying out ultrasonic oscillation for 15min to obtain a mixture; the power of ultrasonic oscillation is 250W, and the frequency is 30KHz;
s3: adding a methanol-hydrochloric acid mixed solution into the mixture, heating and refluxing for 45min at 60 ℃, filtering, and collecting filtrate; the volume ratio of the methanol to the hydrochloric acid in the methanol-hydrochloric acid mixed solution is 4:1, and the volume ratio of the mixture to the methanol-hydrochloric acid mixed solution is 1:2;
s4: adding an equal volume of ethyl acetate into the filtrate, shaking for 2min, standing for 40min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s5: purifying the crude product by using XDA-5 macroporous resin column as purification column and 70% ethanol solution as eluent, collecting eluent, concentrating, and drying.
Example 2
A willow leaf extract is extracted by the following process:
s1: mixing fresh willow leaves with acetic acid solution with volume concentration of 5% according to a feed liquid ratio of 1g to 5mL, and pulping to obtain slurry;
s2: mixing the slurry with a sodium chloride solution with the concentration of 0.1wt% according to the volume ratio of 1:1, and carrying out ultrasonic vibration for 20min to obtain a mixture; the power of ultrasonic oscillation is 200W, and the frequency is 25KHz;
s3: adding a methanol-hydrochloric acid mixed solution into the mixture, heating and refluxing at 45 ℃ for 60min, filtering, and collecting filtrate; the volume ratio of the methanol to the hydrochloric acid in the methanol-hydrochloric acid mixed solution is 3:1, and the volume ratio of the mixture to the methanol-hydrochloric acid mixed solution is 1:1;
s4: adding an equal volume of ethyl acetate into the filtrate, shaking for 2min, standing for 30min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s5: purifying the crude product by using XDA-5 macroporous resin column as purification column and 70% ethanol solution as eluent, collecting eluent, concentrating, and drying.
Example 3
A willow leaf extract is extracted by the following process:
s1: mixing fresh willow leaves with acetic acid solution with volume concentration of 10% according to the feed liquid ratio of 1g to 10mL, and pulping to obtain slurry;
s2: mixing the slurry with a sodium chloride solution with the concentration of 0.5wt% according to the volume ratio of 1:3, and carrying out ultrasonic oscillation for 10min to obtain a mixture; the power of ultrasonic oscillation is 300W, and the frequency is 40KHz;
s3: adding a methanol-hydrochloric acid mixed solution into the mixture, heating and refluxing for 30min at 100 ℃, filtering, and collecting filtrate; the volume ratio of the methanol to the hydrochloric acid in the methanol-hydrochloric acid mixed solution is 5:1, and the volume ratio of the mixture to the methanol-hydrochloric acid mixed solution is 1:3;
s4: adding an equal volume of ethyl acetate into the filtrate, shaking for 2min, standing for 45min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s5: purifying the crude product by using XDA-5 macroporous resin column as purification column and 70% ethanol solution as eluent, collecting eluent, concentrating, and drying.
Comparative example 1
A willow leaf extract is extracted by the following process:
s1: mixing fresh willow leaves with sodium chloride solution with concentration of 0.3wt% according to a feed-liquid ratio of 1g to 8mL, and pulping to obtain slurry;
s2: ultrasonically oscillating the slurry for 15min to obtain a mixture; the power of ultrasonic oscillation is 250W, and the frequency is 30KHz;
s3: adding a methanol-hydrochloric acid mixed solution into the mixture, heating and refluxing for 45min at 60 ℃, filtering, and collecting filtrate; the volume ratio of the methanol to the hydrochloric acid in the methanol-hydrochloric acid mixed solution is 4:1, and the volume ratio of the mixture to the methanol-hydrochloric acid mixed solution is 1:2;
s4: adding an equal volume of ethyl acetate into the filtrate, shaking for 2min, standing for 40min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s5: purifying the crude product by using XDA-5 macroporous resin column as purification column and 70% ethanol solution as eluent, collecting eluent, concentrating, and drying.
Comparative example 2
A willow leaf extract is extracted by the following process:
s1: mixing fresh willow leaves with acetic acid solution with volume concentration of 8% according to the feed liquid ratio of 1g to 8mL, and pulping to obtain slurry;
s2: adding a methanol-hydrochloric acid mixed solution into the slurry, heating and refluxing for 45min at 60 ℃, filtering, and collecting filtrate; the volume ratio of the methanol to the hydrochloric acid in the methanol-hydrochloric acid mixed solution is 4:1, and the volume ratio of the slurry to the methanol-hydrochloric acid mixed solution is 1:2;
s3: adding an equal volume of ethyl acetate into the filtrate, shaking for 2min, standing for 40min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s4: purifying the crude product by using XDA-5 macroporous resin column as purification column and 70% ethanol solution as eluent, collecting eluent, concentrating, and drying.
Comparative example 3
A willow leaf extract is extracted by the following process:
s1: mixing fresh willow leaves with acetic acid solution with volume concentration of 8% according to the feed liquid ratio of 1g to 8mL, and pulping to obtain slurry;
s2: mixing the slurry with a sodium chloride solution with the concentration of 0.3wt% according to the volume ratio of 1:2, and carrying out ultrasonic oscillation for 15min to obtain a mixture; the power of ultrasonic oscillation is 250W, and the frequency is 30KHz;
s3: adding methanol solution into the mixture, heating and refluxing at 60 ℃ for 45min, filtering, and collecting filtrate; the volume fraction of the methanol solution is 75%, and the volume ratio of the mixture to the methanol solution is 1:2;
s4: adding an equal volume of ethyl acetate into the filtrate, shaking for 2min, standing for 40min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s5: purifying the crude product by using XDA-5 macroporous resin column as purification column and 70% ethanol solution as eluent, collecting eluent, concentrating, and drying.
Comparative example 4
A willow leaf extract is extracted by the following process:
s1: mixing fresh willow leaves with water according to a feed liquid ratio of 1g to 8mL, and pulping to obtain slurry;
s2: adding a methanol-hydrochloric acid mixed solution into the slurry, heating and refluxing for 45min at 60 ℃, filtering, and collecting filtrate; the volume ratio of the methanol to the hydrochloric acid in the methanol-hydrochloric acid mixed solution is 4:1, and the volume ratio of the slurry to the methanol-hydrochloric acid mixed solution is 1:2;
s3: adding an equal volume of ethyl acetate into the filtrate, shaking for 2min, standing for 40min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s4: purifying the crude product by using XDA-5 macroporous resin column as purification column and 70% ethanol solution as eluent, collecting eluent, concentrating, and drying.
Experimental example 1: yield of the extract
The yield of the willow herb extract was calculated according to the following formula, and the results are shown in table 1.
TABLE 1 extract yield of willow leaf
Yield (%) | |
Example 1 | 10.24 |
Example 2 | 9.60 |
Example 3 | 10.67 |
Comparative example 1 | 7.36 |
Comparative example 2 | 7.80 |
Comparative example 3 | 8.28 |
Comparative example 4 | 5.94 |
As can be seen from table 1, the extraction process according to the present application gave an extract yield of 9.6% or more, whereas the extraction process according to the comparative example gave a reduced extract yield, because:
comparative example 1 compared with example 1, the cell wall of the willow herb was not effectively broken without the acetic acid treatment, and the stability of the effective ingredient was not ensured, resulting in a decrease in the yield of the final extract.
Comparative example 2, compared with example 1, the osmotic pressure of the willow cells could not be adjusted during the extraction without sodium chloride treatment, and the active ingredients in the cells could not be released completely, resulting in a decrease in the yield of the final extract.
Comparative example 3 was compared with example 1, only methanol was added during the heat refluxing, but hydrochloric acid was absent, and the cell wall of the willow leaf was not further damaged, so that the total release of the internal active ingredient was not possible, and the yield of the extract was lowered.
Comparative example 4 compared with example 1, the extract was obtained by extracting the willow leaf with only a mixed solution of methanol and hydrochloric acid, the cell wall was hardly destroyed, and the active ingredient in the cell was hardly released, resulting in a lower yield of the extract.
Experimental example 2: inhibition rate of tyrosinase by extract
1. Preparation of the solution
Preparation of Phosphate Buffered Saline (PBS): accurately weighing 71.6g of disodium hydrogen phosphate and 31.2g of sodium dihydrogen phosphate respectively, adding deionized water for full dissolution, respectively transferring into 1000mL volumetric flask to obtain solutions with constant volume of 0.2moL/L, uniformly mixing at a ratio of 51:49, and regulating pH to 6.8.
Preparing a tyrosine solution: accurately weighing 0.01g tyrosinase in a 100mL volumetric flask, and fixing the volume by using PBS solution to obtain the product.
Preparing a dopamine solution: accurately weighing a certain amount of dopamine, adding a small amount of 0.1moL/L hydrochloric acid for pre-dissolving, preparing 1.5g/L dopamine solution by using PBS solution after complete dissolving, and storing at 4 ℃ in a dark place.
Preparation of sample solution: the extracts obtained in examples and comparative examples were prepared as 0.4g/L sample solutions with PBS solution, respectively.
2. Measurement method
Respectively adding PBS solution, sample solution and tyrosinase solution into each test tube according to the reaction composition in Table 2, mixing, reacting in a constant temperature water bath at 37deg.C for 10min, respectively rapidly adding 1mL dopamine solution, mixing, placing into water bath, reacting for 5min, and immediately measuring A after reacting for 5min λ=475 A is measured separately C1 、A C2 、A T1 And A T2 Group 3 were tested in parallel. The inhibition rate of tyrosinase by the extract was calculated as follows:
inhibition ratio = [1- (A) T1 -A T2 /A C1 -A C2 )]*100%
Wherein, C1 is blank group, C2 is used for blank zeroing, T1 is sample group, and T2 is used for sample zeroing.
TABLE 2 composition of reaction solution
Reaction set | PBS/mL | Stock solution/mL | tyrosinase/mL |
C1 | 13 | 2 | |
C2 | 15 | ||
T1 | 11 | 2 | 2 |
T2 | 13 | 2 |
The inhibition rate of tyrosinase by the extract is shown in table 3.
TABLE 3 inhibition of tyrosinase by willow leaf extract
Inhibition ratio (%) | |
Example 1 | 78.25 |
Example 2 | 76.56 |
Example 3 | 80.00 |
Comparative example 1 | 67.24 |
Comparative example 2 | 70.31 |
Comparative example 3 | 72.44 |
Comparative example 4 | 59.30 |
As can be seen from Table 3, the extract obtained by the extraction process of the application has a high inhibition rate on tyrosinase, and can remarkably inhibit melanin generation, thereby producing good whitening effect.
The extraction process in the comparative example can not completely extract the active ingredients in the willow leaf, and the content of the active ingredients is low, so that the inhibition rate of tyrosinase is lower than that of the example, and the whitening effect is poor.
Experimental example 3: skin whitening effect
70 healthy subjects (35 men and 35 women) were collected, equally divided into 7 groups, then an opaque adhesive tape with a through hole (diameter of the through hole is 2 cm) was attached to the arm of the subject, and then the additional part of each tester was irradiated with ultraviolet rays at a dose 1.5 times the minimum erythema dose, and skin darkening was induced. After the ultraviolet irradiation, the extracts obtained in examples and comparative examples were applied to the irradiated sites, respectively. And after two months, skin color was measured with a colorimeter (commercially available).
The effect of each extract was judged by determining an "L" value indicating the skin brightness and darkness, which was corrected by a standard plate in the present application, and repeated a plurality of times at one portion to uniformly measure the pigmentation portion. The skin color difference (Δl) between the point at which the application of the extract was started and the point at which the application of the extract was completed was calculated according to the following formula:
Δl=luminance L after two months of experiment-luminance L at the start of experiment
The results are shown in Table 4.
TABLE 4 whitening effect of willow leaf extract
Whitening effect (DeltaL) | |
Example 1 | 2.95 |
Example 2 | 2.74 |
Example 3 | 3.02 |
Comparative example 1 | 2.13 |
Comparative example 2 | 2.18 |
Comparative example 3 | 2.35 |
Comparative example 4 | 1.55 |
As can be seen from Table 4, the extracts obtained in the examples have excellent whitening effect and are effective in reducing melanin deposition. The extract obtained in the comparative example also has a certain whitening effect, but the whitening effect is greatly reduced compared with the extract in the examples due to the lower content of the active ingredients.
While specific embodiments of the application have been described in detail in connection with the examples, it should not be construed as limiting the scope of protection of the patent. Various modifications and variations which may be made by those skilled in the art without the creative effort are within the scope of the patent described in the claims.
Claims (10)
1. The method for extracting the willow leaf extract is characterized by comprising the following steps of:
s1: mixing fresh willow leaf with acetic acid solution according to a feed liquid ratio of 1 g:5-10 mL, and pulping to obtain slurry;
s2: mixing the slurry with sodium chloride solution, and carrying out ultrasonic oscillation for 10-20 min to obtain a mixture;
s3: adding a methanol-hydrochloric acid mixed solution into the mixture, heating and refluxing for 30-60 min at 45-100 ℃, filtering, and collecting filtrate;
s4: adding an organic extractant into the filtrate, standing for 30-45 min, centrifuging, collecting an upper organic layer, and concentrating until the volume is not changed, thus obtaining a crude product;
s5: purifying the crude product by using XDA-5 macroporous resin column as purification column and ethanol solution as eluent, collecting eluent, concentrating, and drying.
2. The extraction method according to claim 1, characterized in that: the volume concentration of the acetic acid solution is 5-10%.
3. The extraction method according to claim 1, characterized in that: the concentration of the sodium chloride solution is 0.1-0.5 wt%, and the volume ratio of the slurry to the sodium chloride solution is 1:1-3.
4. The extraction method according to claim 1, characterized in that: the power of the ultrasonic oscillation is 200-300W, and the frequency is 25-40 KHz.
5. The extraction method according to claim 1, characterized in that: the volume ratio of the methanol to the hydrochloric acid in the methanol-hydrochloric acid mixed solution is 3-5:1.
6. The extraction method according to claim 5, characterized in that: the volume ratio of the mixture to the methanol-hydrochloric acid mixed solution is 1:1-3.
7. The extraction method according to claim 1, characterized in that: the organic extractant is ethyl acetate, and the filtrate is mixed with ethyl acetate in an equal volume.
8. The extract of willow leaf obtained by the extraction method according to any one of claims 1 to 7.
9. Use of the willow leaf extract of claim 8 in the preparation of cosmetics.
10. The use according to claim 9, wherein: the cosmetic is a whitening cosmetic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311401209.4A CN117180161A (en) | 2023-10-26 | 2023-10-26 | Willow leaf extract and extraction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311401209.4A CN117180161A (en) | 2023-10-26 | 2023-10-26 | Willow leaf extract and extraction method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117180161A true CN117180161A (en) | 2023-12-08 |
Family
ID=88998224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311401209.4A Pending CN117180161A (en) | 2023-10-26 | 2023-10-26 | Willow leaf extract and extraction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117180161A (en) |
-
2023
- 2023-10-26 CN CN202311401209.4A patent/CN117180161A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109157447B (en) | Application of cherokee rose fruit extract in whitening, moisturizing and anti-aging skin care product and preparation method thereof | |
CN107802559A (en) | Lightening compositions and its production and use | |
CN113456551A (en) | Method for extracting sunscreen component from agilawood leaves and sunscreen composition | |
CN118286104A (en) | Sustained-release whitening composition and preparation method and application thereof | |
CN108785214B (en) | Blue light damage resistant compound and application thereof in cosmetics | |
CN113797132A (en) | Whitening sunscreen composition, preparation method thereof and whitening sunscreen emulsion containing composition | |
KR101639578B1 (en) | Cosmetic composition containing Ocimum basilicum seed extract | |
KR100515418B1 (en) | Anti-wrinkle cosmetics composition comprising natural herb extracts | |
CN117180161A (en) | Willow leaf extract and extraction method and application thereof | |
KR20010026175A (en) | whitening composition including the natural plant extract | |
CN110604713A (en) | Essence containing water shield extract and preparation method thereof | |
CN114886834B (en) | Whitening essence and preparation method thereof | |
CN115300435A (en) | Freckle-removing and moisturizing essence and preparation method thereof | |
CN112062870B (en) | Polysaccharide with whitening and moisturizing activities, whitening and moisturizing cream containing polysaccharide and preparation method of whitening and moisturizing cream | |
CN109568234B (en) | Gel type safflower whitening mask and preparation method thereof | |
CN109010572A (en) | A kind of Chinese medicine composition and its preparation method and application with sun-proof synergy and anti-aging effects | |
KR101017586B1 (en) | Cosmetic composition for skin whitening | |
KR100466379B1 (en) | Composition for skin whitening | |
CN112972332A (en) | Rose whitening essence and preparation method thereof | |
CN109745274B (en) | Tear-type traditional Chinese medicine whitening mask and preparation method thereof | |
KR20030055950A (en) | Cosmetic composition containing punica granatum l. extract for anti-aging effect | |
KR20010093861A (en) | Whitening composition including the extract of the fruits of Melia azedarach or M. toosendan | |
CN114292889B (en) | Preparation method and application of amorpha fruticosa flower polysaccharide | |
CN111789785A (en) | Plant extract for inhibiting tyrosinase activity, preparation method and application thereof in cosmetics | |
CN112076105A (en) | Anti-allergy sunscreen repair multi-effect composition with sunscreen enhancing capacity and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |